Showing 61 - 80 results of 52,402 for search '(( a non decrease ) OR ( 50 ((ns decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 0.96s Refine Results
  1. 61

    Annual number of outpatient visits in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

    Published 2025
    “…<p>In the recurrence group, mean outpatient visits (± standard deviation) decreased from 13.6 ± 3.0 to 11.9 ± 5.0, 8.1 ± 3.9, and 7.8 ± 3.2 at 1, 2, and 3 years postoperatively, respectively (Kruskal-Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”
  2. 62
  3. 63
  4. 64
  5. 65
  6. 66

    The <i>P[syt<sup>P-L</sup>]</i> mutation decreases the Ca<sup>2+</sup> affinity of release and vesicular release probability, but the readily releasable pool is unchanged. by Mallory C. Shields (4474210)

    Published 2017
    “…<p>(A) Mean EJP amplitudes from <i>+/-;P[syt<sup>WT</sup>]/+</i> (filled black circles) and <i>+/-;P[syt<sup>P-L</sup>]/+</i> (filled red circles) larvae at Ca<sup>2+</sup> levels ranging from 0.05 mM—5.0 mM. …”
  7. 67
  8. 68
  9. 69
  10. 70
  11. 71
  12. 72

    SUI-sEVs decreased the migration ability of primary cultured fibroblasts. by Xiaoyan Sun (28501)

    Published 2021
    “…SUI-sEVs significant decreased the migration ability of primary cultured fibroblasts at 48h when compared to the cells in control group and treated with the non SUI-sEVs. …”
  13. 73

    miR-155 suppresses atherosclerotic plaque progression, reduces macrophage accumulation, as well as decreases TNF-a and IL-6 levels in the thoracic aorta of ApoE<sup>−/−</sup> mice.... by Jianhua Zhu (50548)

    Published 2012
    “…Paraffin-embedded serial sections were stained with HE, rat anti-mouse CD68 antibody, and rat non-specific IgG (B) or rabbit anti-mouse TNF-a and IL-6 antibody, as well as rabbit non-specific IgG, respectively (C) and (D), at a 400× magnification. …”
  14. 74
  15. 75

    Mean change in incidence and diagnoses if testing rates decrease. by Richard T. Gray (282417)

    Published 2013
    “…<p>Change in incidence (A) and diagnoses (B) if testing rates decrease by 30% and 50% relative to the current testing rate.…”
  16. 76
  17. 77
  18. 78
  19. 79
  20. 80